buy cbdc currency Top Top stories

Jingmen, the Yiwei Lithium Energy Super Energy Storage Factory, was put into operation, with the largest production capacity in Central China. Following the opening and operation of Jingjing High-speed Railway, on December 10th, the Yiwei Lithium Energy 60GWh Super Energy Storage Factory project was officially put into operation in the new energy and new materials industrial park of Duodao District, Jingmen High-tech Zone, becoming a lithium battery production base with the largest production capacity and the longest industrial chain in Central China. The total investment of this project is 10.8 billion yuan, and the first phase covers an area of about 700 mu. It mainly produces MB56 large iron-lithium energy storage batteries, and its cell capacity and cycle times are 25% and 20% higher than those of the same industry products respectively, which are widely used in electric energy storage, ship energy storage and other fields. Taking an electric ship as an example, the voyage distance can be increased by about 40% by using MB56 battery, and the battery life can be extended by about two years.Good shop: shareholder Dayong Co., Ltd. reduced its holdings by 3% in this reduction plan, which has reached the upper limit of the reduction plan. The good shop announced that during the period from December 2, 2024 to December 10, 2024, shareholder Dayong Co., Ltd. reduced its holdings by 4,560,400 shares, accounting for 1.14% of the company's total share capital. As of December 11, 2024, shareholder Dayong Co., Ltd. has reduced its shareholding by 3% in this reduction plan, which has reached the upper limit of the reduction plan, and the implementation of this reduction plan has been completed.Huayuan Real Estate: It is planned to transfer the assets and liabilities related to real estate development business to Huayuan Group, the controlling shareholder of the company. Huayuan Real Estate announced the change, and the company is planning major asset sales and related transactions. It is planned to transfer the assets and liabilities related to real estate development business to Huayuan Group, the controlling shareholder of the company, that is, the company plans to transfer 100% equity of Huayuan Real Estate. As of the evaluation benchmark date (April 30, 2024), the company's receivables from Huayuan Real Estate and its subsidiaries are as follows.

Analysts commented on the US CPI in November: the data is in line with expectations, and there may be four interest rate cuts next year. Brian Jacobsen, chief economist of Annex Wealth Management, said: "There is nothing unexpected in the CPI report, and everything is in line with expectations. Housing cost is still the main driver of inflation. With the employment report and inflation report, nothing can stop the Fed from cutting interest rates by 25 basis points next week. What will be exciting is the summary of the Fed's economic forecast. There may be four interest rate cuts in 2025, and inflation will eventually fall to the target level. "Kremlin: It is very important to ensure the safety of our bases and diplomatic missions.Zhangjiang Haoxin, the service platform of Pudong IC industry, was officially unveiled. On December 11th, Shanghai IC Industry Development Forum 2024 and the 30th IC Design Exhibition were held in Pudong, Shanghai. At the meeting, Professor Wei Shaojun, Chairman of Integrated Circuit Design Branch of China Semiconductor Industry Association, and Wu Qiang, member of the Standing Committee of Pudong District Committee and deputy head of the district, jointly unveiled Shanghai Zhangjiang Haoxin Enterprise Management Co., Ltd. (hereinafter referred to as Zhangjiang Haoxin), which will add new momentum to the development of integrated circuit industry in Shanghai and even the whole country and promote the higher quality development of regional integrated circuit industry.

The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)Pakistan KSE-100 index rose 0.5% to 109,693.20.Kremlin: We keep in touch with those who control the situation in Syria.